Indivior PLC to Acquire Opiant Pharmaceuticals Inc Call Transcript

Nov 14, 2022 / 01:00PM GMT

Good day, and thank you for standing by. Welcome to the Indivior Acquisition of Opiant Pharmaceuticals Conference Call. (Operator Instructions)

Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Mark Crossley, CEO. Please go ahead.

Mark Crossley - Indivior PLC - CEO & Executive Director

Thank you, Sandra, and good morning, and good afternoon, everyone. Thank you for joining us on such short notice to discuss an exciting development for our company. I'm joined by Ryan Preblick, our Chief Financial Officer; and Christian Heidbreder, our Chief Scientific Officer.

I'll briefly cover the highlights of the transaction we announced today, and then Ryan will cover off the financial aspects and closing conditions, after which we'll open it up for questions and answers. I'd ask that you each please read in full the information on Pages 2 and 3 of the presentation as it is important.

Earlier today, we announced a definitive agreement to acquire Opiant

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
4.6 out of 5 Trustpilot